6,193 reports of this reaction
3.2% of all PAROXETINE HYDROCHLORIDE reports
#1 most reported adverse reaction
DRUG WITHDRAWAL SYNDROME is the #1 most commonly reported adverse reaction for PAROXETINE HYDROCHLORIDE, manufactured by Apotex Corp. There are 6,193 FDA adverse event reports linking PAROXETINE HYDROCHLORIDE to DRUG WITHDRAWAL SYNDROME. This represents approximately 3.2% of all 192,057 adverse event reports for this drug.
PAROXETINE HYDROCHLORIDE has an overall safety score of 78 out of 100. Patients taking PAROXETINE HYDROCHLORIDE who experience drug withdrawal syndrome should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG WITHDRAWAL SYNDROME is moderately reported among PAROXETINE HYDROCHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to drug withdrawal syndrome, the following adverse reactions have been reported for PAROXETINE HYDROCHLORIDE:
The following drugs have also been linked to drug withdrawal syndrome in FDA adverse event reports:
DRUG WITHDRAWAL SYNDROME has been reported as an adverse event in 6,193 FDA reports for PAROXETINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG WITHDRAWAL SYNDROME accounts for approximately 3.2% of all adverse event reports for PAROXETINE HYDROCHLORIDE, making it one of the most commonly reported side effect.
If you experience drug withdrawal syndrome while taking PAROXETINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.